Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000208

Director sold 3,080 shares at $27.07 ($83,376)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-01 Sale : show line 1 in the form 10b5-1 −3,080 $27.07 $83,376 112,076 D
Open-market sales · 3,080 sh · avg $27.07 · $83,376
Loading xslF345X05/wk-form4_1730841680.xml…